Treatment of vulvovaginal erosive and stenosing lichen planus by surgical dilatation and methotrexate

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 3, 2007, Pages 339-343

  Kortekangas Savolainen, Outi ^a   Kiilholma, Pentti ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Methotrexate; Surgical dilatation; Vulvovaginal lichen planus

Indexed keywords

ACICLOVIR; CORTICOSTEROID; ESTRADIOL; ESTROGEN; FOLIC ACID; GENTAMICIN; METHOTREXATE; STEROID; TACROLIMUS; TETRACYCLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENERAL AND MISCELLANEOUS PROCEDURES AND TECHNIQUES; HERPES SIMPLEX; HUMAN; LICHEN PLANUS; PRIORITY JOURNAL; REMISSION; RESTENOSIS; VAGINA ATROPHY; VAGINA DILATATION;

ADRENAL CORTEX HORMONES; AGED; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; DILATATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MIDDLE AGED; OINTMENTS; RECURRENCE; TACROLIMUS; VULVAR LICHEN SCLEROSUS;

EID: 33846955441     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340601110721     Document Type: Article

References (29)

1. Lewis FM. Vulval LP. Br J Dermatol. 1998;138:569-75.
2. Micheletti L, Preti M, Bogliatto F, Zanotto-Valentino MC, Ghiringhello B, Massobrio M. Vulval LP in the practice of a vulval clinic. Br J Dermatol. 2000;143(6):1349-50.
3. Kirtschig G, Wakelin SH, Wojnarowska F. Mucosal vulval LP: outcome, clinical and laboratory features. J Eur Acad Dermatol Venereol. 2005;19(3):301-7.
4. Oyama N, Setterfield JF, Gratain MJ, Bhogal BS, Shirlaw P, Challacombe SJ, et al. Oral and genital lichenoid reaction associated with circulating autoantibodies to desmoplakin I and II: A novel target antigen or example of epitope spreading? J Am Acad Dermatol. 2003;48:433-8.
5. Pelisse M, Leibowitch M, Sedel D, Hewitt J. Un nouveau syndrome vulvo-vagino-gingival: lichen plan rosif plurimuqueux. Ann Derm Venereol. 1982;109:797.
6. Edwards L. Vulval LP. Arch Dermatol. 1989;125:1677-80.
7. Eisen D. The vulvovaginal-gingival syndrome of LP. Arch Dermatol. 1994;130(11):1379-82.
8. Rogers RS 3rd, Eisen D. Erosive oral LP with genital lesion: the vulvovaginal-gingival syndrome and the peno-gingival syndrome. Dermatol Clin. 2003;21(1):91-8.
9. Setterfield JF, Neill S, Shorlaw PJ, Theron J, Vaughan R, Escudier M, et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol. 2006;55(1):98-113.
10. Lotery HE, Galask RP. Erosive LP of the vulva and vagina. Obstet Gynecol. 2003;101(5, Part 2):1121-5.
11. Mann MS, Kaufman RH. Erosive LP of the vulva. Clin Obstet Gynecol. 1991;34:605-14.
12. Anderson M, Kutzner S, Kaufman RH. Treatment of vulvovaginal LP with vaginal hydrocortisone suppositories. Obstet Gynecol. 2002;100:359-62.
13. Cooper SM, Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch Dermatol. 2006;142:289-94.
14. Kirtschig G, van der Meulen AJ, Ion Lipan JW, Stoof TJ. Successful treatment of erosive vulvovaginal LP with topical tacrolimus. Br J Dermatol. 2002;147(3):625-7.
15. Jensen JT, Bird M, LeClair C. Patient satisfaction after the treatment of vulvovaginal erosive LP with topical clobetasol and tacrolimus: a survey study. Am J Obstet Gynecol. 2004;190:1759-65.
16. Byrd JA, Davis MDP, Rogers RS III. Recalcitrant symptomatic vulvar LP: response to topical tacrolimus. Arch Dermatol. 2004;140:715-20.
17. Lonsdale-Eccles AA, Velangi S. Topical pimecrolimus in the treatment of genital LP: a prospective case series. Br J Dermatol. 2005;153:390-4.
18. Borrego L, Ruiz-Rodriquez R, Ortiz de Frutos J, Vanaclocha Sebastin F, Iglesias Diez L. Vulvar LP treated with topical cyclosporine. Arch Dermatol. 1993;129(6):794.
19. Ridley CM. Chronic erosive vulval disease. Clin Exp Dermatol. 1990;15:245-52.
20. Ridley CM, Robinson AJ, Oriel JD. Vulval disease. A practical guide to diagnosis and management. Arnold, 2000:132.
21. Paul MA, Jorizzo JL, Fleischer AB. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. J Am Acad Dermatol. 1994;31(4):620-5.
22. Bara C, Maillard H. Methotrexate for bullous pemphidoid: preliminary study. Arch Dermatol. 2003;139:1506-7.
23. Nylander Lundqvist E, Wahlin YB, Hofer PÅ. Methotrexate supplemented with steroid ointments for the treatment of severe erosive lichen planus. Acta Derm Venereol. 2002;82(1):63-4.
24. Kazlow Stern D, Tripp JM, Ho VC, Leibwohl M. The use of systemic immune moderators in dermatology: an update. Dermatol Clin. 2005;23(2):259-300.
25. Dubertret L. Methotrexate in dermatology and rheumatology. (Editorial). Joint Bone Spine. 2005;72(2):104-5.
26. Franck JM, Young AW Jr. Squamous cell carcinoma in situ arising with LP of the vulva. Dermatol Surg. 1995;21(10):890-4.
27. Zaki I, Dalziel KL, Solomonsz FA, Stevens A. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exp Dermatol. 1996;21(5):334-7.
28. Derrick EK, Ridley CM, Kobza-Black A, McKee PH, Neill SM. A clinical study of 23 cases of female anogenital carcinoma. Br J Dermatol. 2000;143(6):1217-23.
29. Becker J, Houben R, Vetter C, Bröcker E. The carcinogenic potential of tacrolimus ointment beoynd immune suppression: a hypothesis creating case report. BMC Cancer 2006;6:7 doi 10.1186/1471-2407-6-7.